What is the prevalence of Small Fiber Neuropathy?

Small Fiber Neuropathy (SFN) is estimated to have a prevalence of approximately 13 to 53 per 100,000 individuals, though these figures are likely underestimates due to challenges in clinical diagnosis. While Small Fiber Neuropathy is not considered ultra-rare, its true incidence remains difficult to quantify because many patients experience significant delays in receiving an accurate clinical diagnosis.

What is the estimated prevalence and incidence of Small Fiber Neuropathy?

Determining the exact prevalence of Small Fiber Neuropathy is complex because it is often a manifestation of an underlying condition rather than a standalone disease. Current epidemiological studies, such as those cited by the NIH GARD, estimate the prevalence to be between 13 and 53 per 100,000 people. Incidence—the number of new cases diagnosed each year—is even more difficult to track, as many patients remain undiagnosed for years while seeking answers for chronic pain. In our DiseaseMaps.org community, 209 people with Small Fiber Neuropathy have joined to share their lived experiences, highlighting that while the condition is documented, it remains under-recognized in general clinical practice.

Who is most affected by Small Fiber Neuropathy?

Small Fiber Neuropathy can affect individuals of any age, though it is most frequently diagnosed in adults. Research indicates that the condition often presents in middle age, typically between 40 and 60 years old, though pediatric cases are documented, particularly when the condition is linked to genetic mutations. Regarding gender distribution, data suggests that Small Fiber Neuropathy affects males and females, though some clinical cohorts report a slightly higher prevalence in females, potentially due to the higher association of SFN with autoimmune conditions which are also more common in women.

Why is accurate data for Small Fiber Neuropathy so difficult to obtain?

The primary challenge in mapping the true prevalence of Small Fiber Neuropathy is that standard diagnostic tools, such as electromyography (EMG) and nerve conduction studies, often appear normal because they only measure large nerve fibers. Because the small nerve fibers (A-delta and C fibers) are too thin to be detected by these standard tests, many patients are misdiagnosed or dismissed. Accurate diagnosis typically requires a skin punch biopsy to assess intraepidermal nerve fiber density (IENFD). Consequently, the following factors contribute to the gap in data:

• Diagnostic Sensitivity: Many clinicians are not trained in the specific protocols required to identify Small Fiber Neuropathy.


• Underlying Etiology: Because SFN is often secondary to diabetes, sarcoidosis, or autoimmune diseases, it is frequently coded under the primary condition rather than as Small Fiber Neuropathy itself.


• Symptom Overlap: Patients often present with non-specific burning or tingling, leading to misdiagnoses of fibromyalgia or anxiety.

Is there geographic or ethnic variation in Small Fiber Neuropathy?

There is currently no robust evidence to suggest that Small Fiber Neuropathy is restricted to specific geographic regions or ethnic groups. However, because the condition can be caused by genetic variants (such as mutations in the SCN9A gene), there may be clusters of hereditary Small Fiber Neuropathy within specific populations or families. As clinical genetic testing becomes more accessible, we expect to see more accurate data regarding these hereditary forms of the disease.

Next steps

• Consult a neurologist specializing in peripheral nerve disorders or neuromuscular medicine for specialized diagnostic testing.


• Request a skin punch biopsy if you suspect you have Small Fiber Neuropathy but have had "normal" EMG/NCS results.


• Join the DiseaseMaps.org community to connect with others and track your symptom progression.


• Maintain a detailed symptom log to help your physician identify potential triggers or associated systemic conditions.

Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Small Fiber Neuropathy overview.


• Orphanet: Rare disease database entries for peripheral neuropathies.


• PubMed/NCBI: "Epidemiology and clinical features of small fiber neuropathy" (Review articles).


• The Neuropathy Association: Patient resources and clinical guidelines for small fiber nerve disorders.